Adalat
Active ingredient: Nifedipine
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Adults with hypertension or stable angina may be prescribed Adalat, which contains nifedipine, a calcium channel blocker. It relaxes arterial muscle, lowering vascular resistance and improving coronary blood flow. The prescribed amount is individualised according to the formulation and clinical response.
Product information
Adalat contains nifedipine, a dihydropyridine calcium channel blocker. Its ATC code is C08CA05.
Nifedipine Mechanism of Action
Calcium channel blockers limit the movement of calcium required for vascular muscle contraction. With less calcium entering these cells, arterial walls relax. The resulting vasodilation can also produce headache, flushing, palpitations, dizziness or ankle swelling in some patients.
The effect is mainly vascular. That distinguishes nifedipine from medicines whose principal action is to slow the heart rate or reduce cardiac contractility.
Prescription Status and Product Identity
Adalat is a prescription nifedipine treatment for adults with suitable cardiovascular indications. The exact strength, release design and dosing schedule determine how the tablets should be used. Adalat LA is a prolonged-release nifedipine formulation, while other Adalat products may use different release systems.
The formulation matters. Tablets containing the same active ingredient are not automatically interchangeable because their release rate and clinical duration can differ.
How it affects the body
Nifedipine reduces calcium entry into vascular smooth-muscle cells, allowing arteries to relax and widening the passage through which blood flows.
Calcium channel blockers limit the movement of calcium required for vascular muscle contraction. With less calcium entering these cells, arterial walls relax. The resulting vasodilation can also produce headache, flushing, palpitations, dizziness or ankle swelling in some patients.
The effect is mainly vascular. That distinguishes nifedipine from medicines whose principal action is to slow the heart rate or reduce cardiac contractility.
Ingredients
Adalat contains nifedipine, a dihydropyridine calcium channel blocker. Its ATC code is C08CA05. Nifedipine reduces calcium entry into vascular smooth-muscle cells, allowing arteries to relax and widening the passage through which blood flows.
Lower arterial resistance can reduce blood pressure and decrease the workload placed on the heart. Nifedipine may also improve blood flow through the coronary arteries, which helps prevent episodes of stable or vasospastic angina when prescribed for that purpose. It controls cardiovascular symptoms but does not remove the underlying causes of hypertension or coronary artery disease.
Nifedipine Mechanism of Action
Calcium channel blockers limit the movement of calcium required for vascular muscle contraction. With less calcium entering these cells, arterial walls relax. The resulting vasodilation can also produce headache, flushing, palpitations, dizziness or ankle swelling in some patients.
The effect is mainly vascular. That distinguishes nifedipine from medicines whose principal action is to slow the heart rate or reduce cardiac contractility.
Prescription Status and Product Identity
Adalat is a prescription nifedipine treatment for adults with suitable cardiovascular indications. The exact strength, release design and dosing schedule determine how the tablets should be used. Adalat LA is a prolonged-release nifedipine formulation, while other Adalat products may use different release systems.
The formulation matters. Tablets containing the same active ingredient are not automatically interchangeable because their release rate and clinical duration can differ.
Dosage and administration
The prescribed amount per intake is set individually for each person. It depends on the formulation, treatment response, age, liver function and concomitant medicines.
- Take Adalat exactly at the prescribed frequency and time.
- Swallow prolonged-release tablets whole with water.
- Do not crush, chew or split a modified-release tablet unless a qualified medicine professional confirms that the specific product permits it.
- Keep the daily routine consistent.
- Record blood-pressure readings when monitoring has been requested.
- Avoid grapefruit and grapefruit juice unless the treating clinician has specifically assessed them as suitable.
- Do not change the dose because one reading is higher or lower than usual.
Nifedipine exposure can rise with grapefruit, creating a greater risk of flushing, headache, dizziness, palpitations or hypotension. This interaction is described in official nifedipine prescribing information [2].
Gradual dose adjustment may be used when clinically appropriate. Independent increases can produce marked hypotension, fainting or a rapid heartbeat. A missed dose should not be compensated for by taking two doses together.
When not to use it
A clinician must also assess significant hypotension, cardiogenic shock, certain unstable cardiac conditions and severe aortic stenosis before treatment is used.
Medical Conditions Requiring Review
Extra assessment is needed with:
- Very low blood pressure
- Recent heart attack or unstable angina
- Heart failure or significant valve disease
- Severe aortic stenosis
- Liver impairment
- Pregnancy or breastfeeding
- Recurrent fainting
- Marked ankle swelling before treatment begins
These factors do not all create an automatic prohibition, but they can change the balance between benefit and harm. Prescribing information for nifedipine requires consideration of blood pressure, cardiovascular status and hepatic function.
Medicine and Food Interactions
Important interaction groups include:
- Other blood-pressure medicines, which may produce excessive hypotension
- Strong CYP3A4 inhibitors, which may raise nifedipine exposure
- CYP3A4 inducers, which may reduce exposure
- Grapefruit and grapefruit juice, which may increase exposure
- Alcohol, which can add to dizziness and blood-pressure lowering
- Medicines affecting heart rate or cardiac conduction
- Certain anti-infective, anticonvulsant and immunosuppressive medicines
When this is not for you
Adalat is not for you if you have a confirmed allergy to nifedipine or a previous serious reaction to the medicine.
Possible side effects
Nifedipine adverse effects are linked mainly to arterial vasodilation. Some settle as the body adapts, while others require treatment review.
Common or recognised effects include:
- Headache
- Flushing or warmth
- Dizziness or light-headedness
- Palpitations
- Constipation
- Ankle or lower-leg swelling
- Tiredness
- Low blood pressure
Ankle swelling is a practical concern. It may become more noticeable later in the day and does not always mean that the medicine is causing fluid retention through heart failure, but new or worsening swelling deserves clinical assessment.
Common Nifedipine Effects
Dizziness is more likely to cause trouble when standing quickly, exercising in heat or combining medicines that lower blood pressure. Sitting down promptly can reduce the chance of a fall.
Do not stop Adalat suddenly solely because mild headache or flushing appears. Treatment changes should be based on the severity, timing and pattern of symptoms.
Urgent Adverse-Reaction Signs
Seek emergency care for:
- Fainting or inability to remain upright
- Severe weakness with very low blood pressure
- Difficulty breathing
- Swelling of the face, lips, tongue or throat
- A widespread blistering or severe rash
- New or worsening chest pain
- A sustained, very rapid or irregular heartbeat
Chest pain requires special attention because it may represent worsening coronary disease rather than a routine medicine effect.
Adverse-Event Reporting
Suspected adverse reactions can be reported through the MHRA Yellow Card scheme in the United Kingdom. The MHRA describes Yellow Card as a pharmacovigilance route for reporting suspected medicine and vaccine reactions [3]. UAE residents should use the applicable local pharmacovigilance route overseen by MOHAP. Reporting does not replace urgent treatment.
Therapeutic indications
Adalat is prescribed mainly for high blood pressure and angina. In hypertension, arterial relaxation lowers resistance against which the heart pumps. In chronic stable angina, treatment can reduce the frequency of exertional chest discomfort; in vasospastic angina, it can help limit coronary artery spasm.
Hypertension Treatment
Nifedipine lowers arterial pressure through vasodilation. Blood-pressure readings can improve without producing a noticeable sensation, so feeling well does not prove that treatment is no longer needed.
The amount per intake is selected individually. Clinicians consider the formulation, response, age, liver function and other medicines that may lower blood pressure. NICE hypertension guidance supports regular blood-pressure assessment and treatment adjustment according to the person’s readings and risk profile [1].
Angina Management
Adalat may be used as maintenance treatment for stable angina or vasospastic angina. It is not a substitute for an emergency action plan.
Sudden, severe, prolonged or rapidly worsening chest pain requires urgent medical assessment. Taking an extra Adalat dose is not a safe response to unexplained acute chest pain.
Comparison
Nifedipine products can differ in release mechanism, duration, strength and dosing frequency. Adalat LA is designed for prolonged release. Adalat MR and ADALAT CRONO indicate modified-release approaches in some product ranges, while Adalat 10 mg Capsule is an immediate-release presentation.
| Product name | Main clinical distinction | Safe interpretation |
|---|---|---|
| Adalat LA | Prolonged nifedipine release | Follow its own schedule |
| Adalat MR or ADALAT CRONO | Modified-release nifedipine | Do not assume identical duration |
| Adalat 10 mg Capsule | Immediate-release nifedipine | Do not convert without supervision |
This comparison is for medication safety, not self-directed selection. Products containing nifedipine are not automatically interchangeable, even when their stated strength appears similar.
A common mistake is assuming that one immediate-release capsule can replace one prolonged-release tablet. The same numerical strength can produce a different concentration pattern and a different clinical effect.
Common mistakes
Medication-Use Errors
- Crushing or chewing a prolonged-release tablet
- Doubling the next dose after forgetting one
- Drinking grapefruit juice without discussing it
- Stopping treatment after blood pressure improves
- Treating severe chest pain with an extra tablet
- Ignoring repeated ankle swelling
- Standing quickly after dizziness begins
- Forgetting to mention herbal products or occasional medicines
Blood-pressure improvement often produces no obvious sensation. That is why symptom-based self-adjustment can be misleading.
Clinical Monitoring Points
A clinician may review blood pressure, pulse, dizziness, ankle swelling, chest symptoms, liver function and the complete medicine list. Not every patient requires every test. Monitoring depends on the indication, medical history, treatment duration and accompanying medicines.
Nifedipine can lower blood pressure without correcting every cardiovascular risk factor. Diet, smoking, diabetes, cholesterol and kidney health may still require separate management.
What doctors say
Doctors generally view nifedipine as a vascular medicine whose success is measured through blood-pressure control, fewer angina episodes and acceptable tolerability. The response should be judged over repeated readings and symptom patterns, not one isolated measurement.
A prescriber usually checks the exact formulation before adjusting the dose. They also consider ankle swelling, flushing, dizziness, pulse, liver function when relevant and the full interaction profile.
The main practical limitation is that vasodilation can create symptoms that resemble poor tolerance even when the blood-pressure response is useful. A slower titration or a different treatment plan may be appropriate, but the change should follow an assessment rather than a self-directed stop.
Common questions
What should be discussed with a doctor before starting Adalat?
Before starting, discuss low blood pressure, heart disease, valve disease, liver impairment, pregnancy, breastfeeding and any previous reaction to nifedipine. Provide the full list of prescription medicines, non-prescription products, herbal preparations and supplements. MOHAP pharmacovigilance principles published in 2024 support complete medicine information when assessing suspected reactions. Grapefruit use and other blood-pressure medicines also deserve specific discussion.
Can Adalat tablets be split, crushed or chewed?
Prolonged-release Adalat tablets should generally be swallowed whole unless the exact product information permits another method. Crushing or chewing may disrupt the release design and increase the amount released too quickly. The EMA explains that modified-release formulations require product-specific administration instructions in its 2015 guideline on quality and equivalence of modified-release products. A swallowing problem should lead to a formulation review, not home alteration.
How long does one Adalat dose keep working?
The duration depends on the formulation, strength, absorption and individual response. Prolonged-release products are designed to provide sustained nifedipine exposure, while immediate-release presentations follow a different schedule. The FDA prescribing information from 2011 for extended-release nifedipine describes formulation-specific dosing rather than a universal duration for every Adalat product [2]. Do not repeat a dose early because symptoms or one blood-pressure reading seem unchanged.
Can people under 18 use Adalat?
Adalat is not routinely self-administered by people under 18. Use in children or adolescents requires a paediatric clinician to assess the diagnosis, formulation, dose and monitoring needs. WHO paediatric medicines guidance published in 2021 stresses age-appropriate dosing and formulation selection. An adult’s tablet schedule should never be transferred to a child without a specific prescription.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Adalat Release Formulation and Strength
Adalat tablets are available in formulation-specific strengths and release designs. The product sold on this page should be used according to its prescribed strength and pharmaceutical form, rather than by comparing it with another tablet that contains nifedipine.
| Formulation name | Release principle | Substitution point |
|---|---|---|
| Adalat LA | Prolonged release | Use only at the prescribed strength and schedule |
| Adalat MR or ADALAT CRONO | Modified release | Release characteristics may differ |
| Adalat 10 mg Capsule | Immediate release | Do not convert independently |
A milligram number alone does not establish equivalence. The release mechanism, dosing frequency and clinical response all matter.
Prolonged-Release Tablet Design
A prolonged-release tablet releases nifedipine progressively rather than delivering the whole amount immediately. Crushing, chewing or splitting can change that delivery pattern and may increase adverse effects such as dizziness, flushing or low blood pressure.
Related Release Names and Strengths
The European Medicines Agency and national regulatory documents describe modified-release medicines according to their individual pharmaceutical design, so substitution requires product-specific confirmation rather than simple arithmetic.
Sources
- NICE (2023). Hypertension in adults: diagnosis and management (NG136).
- U.S. Food and Drug Administration (2011). PROCARDIA XL (nifedipine) extended-release tablets prescribing information.
- Medicines and Healthcare products Regulatory Agency (2024). Yellow Card scheme: report suspected side effects.